Výsledky vyhledávání - Small, Eric J
- Zobrazuji výsledky 1 - 20 z 106
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809 Autor Hurwitz, Mark D., Halabi, Susan, Archer, Laura, McGinnis, Lamar S., Kuettel, Michael R., DiBiase, Steven J., Small, Eric J.
Vydáno 2011Text -
11
CTLA4 blockade expands FoxP3(+) regulatory and activated effector CD4(+) T cells in a dose-dependent fashion Autor Kavanagh, Brian, O'Brien, Shaun, Lee, David, Hou, Yafei, Weinberg, Vivian, Rini, Brian, Allison, James P., Small, Eric J., Fong, Lawrence
Vydáno 2008Text -
12
Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy Autor Halabi, Susan, Armstrong, Andrew J., Sartor, Oliver, de Bono, Johann, Kaplan, Ellen, Lin, Chen-Yen, Solomon, Nicole C., Small, Eric J.
Vydáno 2013Text -
13
Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab Autor Kwek, Serena S., Lewis, Jera, Zhang, Li, Weinberg, Vivian, Greaney, Samantha, Harzstark, Andrea, Lin, Amy, Ryan, Charles, Small, Eric J., Fong, Lawrence
Vydáno 2015Text -
14
Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC) Autor Ryan, Charles J, Dutta, Sandipan, Kelly, William K, Russell, Carly, Small, Eric J., Morris, Michael J., Taplin, Mary-Ellen, Halabi, Susan
Vydáno 2019Text -
15
A PHASE II STUDY OF ESTRAMUSTINE, DOCETAXEL, AND BEVACIZUMAB IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER: RESULTS OF CANCER AND LEUKEMIA GROUP B (CALGB) 90006 Autor Picus, Joel, Halabi, Susan, Kelly, W. Kevin, Vogelzang, Nicholas J., Whang, Young E., Kaplan, Ellen B., Stadler, Walter M., Small, Eric J.
Vydáno 2010Text -
16
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer Autor Halabi, Susan, Lin, Chen-Yen, Kelly, W. Kevin, Fizazi, Karim S., Moul, Judd W., Kaplan, Ellen B., Morris, Michael J., Small, Eric J.
Vydáno 2014Text -
17
Optimal MRI sequences for (68)Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer Autor Lake, Spencer T., Greene, Kirsten L., Westphalen, Antonio C., Behr, Spencer C., Zagoria, Ronald, Small, Eric J., Carroll, Peter R., Hope, Thomas A.
Vydáno 2017Text -
18
A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strate... Autor Kaplan, Celia P., Siegel, Adam, Leykin, Yan, Palmer, Nynikka R., Borno, Hala, Bielenberg, Jessica, Livaudais-Toman, Jennifer, Ryan, Charles, Small, Eric J.
Vydáno 2018Text -
19
Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Allian... Autor Eastham, James A., Heller, Glenn, Hillman, David W., Hahn, Olwen M., Parsons, J. Kellogg, Mohler, James L., Small, Eric J., Morris, Michael
Vydáno 2021Text -
20
Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study Autor Borno, Hala T., Zhang, Li, Zhang, Sylvia, Kaplan, Celia, Palmer, Nynikka R., Bell, Alexander, Bakke, Brian, Lin, Amy, Aggarwal, Rahul, Small, Eric J.
Vydáno 2022Text